7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Carcinoma, Neuroendocrine D018278 2 associated lipids
Mastocytoma D034801 3 associated lipids
Progeria D011371 3 associated lipids
Arthritis, Reactive D016918 3 associated lipids
Hearing Loss D034381 3 associated lipids
Periapical Granuloma D010484 3 associated lipids
Respirovirus Infections D010253 3 associated lipids
Arthritis, Rheumatoid D001172 3 associated lipids
Measles D008457 3 associated lipids
Hirsutism D006628 3 associated lipids
Hyperparathyroidism D006961 3 associated lipids
Glucose Metabolism Disorders D044882 3 associated lipids
Cryptosporidiosis D003457 3 associated lipids
Carcinoma, Papillary D002291 3 associated lipids
Myositis, Inclusion Body D018979 3 associated lipids
Mitral Valve Stenosis D008946 3 associated lipids
Takayasu Arteritis D013625 3 associated lipids
Hematoma, Subdural D006408 3 associated lipids
Osteitis Deformans D010001 3 associated lipids
Addison Disease D000224 3 associated lipids
Malocclusion D008310 3 associated lipids
Multiple Sclerosis, Chronic Progressive D020528 3 associated lipids
Arthritis, Psoriatic D015535 3 associated lipids
Paraneoplastic Syndromes D010257 4 associated lipids
Hyperparathyroidism, Secondary D006962 4 associated lipids
Jaw Diseases D007571 4 associated lipids
Heart Valve Diseases D006349 4 associated lipids
Osteoarthritis, Hip D015207 4 associated lipids
Hypercalciuria D053565 4 associated lipids
Systemic Inflammatory Response Syndrome D018746 4 associated lipids
Osteoporosis, Postmenopausal D015663 4 associated lipids
Endocrine System Diseases D004700 4 associated lipids
Biliary Atresia D001656 4 associated lipids
Mitral Valve Insufficiency D008944 4 associated lipids
Fractures, Bone D050723 4 associated lipids
Carcinoma, Lobular D018275 4 associated lipids
Temporomandibular Joint Disorders D013705 4 associated lipids
Osteoarthritis D010003 4 associated lipids
Actinobacillus Infections D000189 4 associated lipids
Periapical Diseases D010483 4 associated lipids
Diabetes Complications D048909 4 associated lipids
Tinnitus D014012 4 associated lipids
Histiocytosis, Non-Langerhans-Cell D015616 4 associated lipids
Aortic Aneurysm, Abdominal D017544 5 associated lipids
Hot Flashes D019584 5 associated lipids
Sclerosis D012598 5 associated lipids
Macular Degeneration D008268 5 associated lipids
Bone Neoplasms D001859 5 associated lipids
Femur Head Necrosis D005271 5 associated lipids
Diabetic Neuropathies D003929 5 associated lipids
Calcinosis D002114 5 associated lipids
Mandibular Diseases D008336 5 associated lipids
beta-Thalassemia D017086 5 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Osteonecrosis D010020 5 associated lipids
Periapical Periodontitis D010485 6 associated lipids
Carcinoma, Pancreatic Ductal D021441 6 associated lipids
Graves Disease D006111 6 associated lipids
Malnutrition D044342 6 associated lipids
Acromegaly D000172 6 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Coronary Stenosis D023921 6 associated lipids
Dental Pulp Necrosis D003790 6 associated lipids
Primary Myelofibrosis D055728 6 associated lipids
Rheumatic Diseases D012216 7 associated lipids
Hepatitis C D006526 7 associated lipids
Plaque, Atherosclerotic D058226 7 associated lipids
Prosthesis-Related Infections D016459 7 associated lipids
Peripheral Arterial Disease D058729 7 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Dyslipidemias D050171 7 associated lipids
Periodontal Attachment Loss D017622 7 associated lipids
Chronic Disease D002908 7 associated lipids
Granuloma, Giant Cell D006101 7 associated lipids
Carcinosarcoma D002296 7 associated lipids
Bone Resorption D001862 7 associated lipids
Peripheral Vascular Diseases D016491 8 associated lipids
Obesity, Morbid D009767 8 associated lipids
Aggressive Periodontitis D010520 8 associated lipids
Thyroid Diseases D013959 8 associated lipids
Diabetes, Gestational D016640 8 associated lipids
Arthralgia D018771 8 associated lipids
Irritable Bowel Syndrome D043183 8 associated lipids
Osteolysis D010014 8 associated lipids
Periodontal Pocket D010514 9 associated lipids
Bacteremia D016470 9 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Mucocutaneous Lymph Node Syndrome D009080 9 associated lipids
Bone Diseases, Metabolic D001851 9 associated lipids
Sleep Apnea, Obstructive D020181 9 associated lipids
Alveolar Bone Loss D016301 10 associated lipids
Hemophilia A D006467 10 associated lipids
Foreign-Body Reaction D005549 10 associated lipids
Cardiomyopathies D009202 10 associated lipids
Osteitis D010000 10 associated lipids
Vision Disorders D014786 10 associated lipids
Lymphatic Metastasis D008207 10 associated lipids
Neoplasms, Experimental D009374 10 associated lipids
Acute Coronary Syndrome D054058 11 associated lipids
Sepsis D018805 11 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Thompson SW and Tonge D Bone cancer gain without the pain. 2000 Nat. Med. pmid:10802700
Honore P et al. Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. 2000 Nat. Med. pmid:10802707
Onyia JE et al. In vivo demonstration that human parathyroid hormone 1-38 inhibits the expression of osteoprotegerin in bone with the kinetics of an immediate early gene. 2000 J. Bone Miner. Res. pmid:10804015
Malyankar UM et al. Osteoprotegerin is an alpha vbeta 3-induced, NF-kappa B-dependent survival factor for endothelial cells. 2000 J. Biol. Chem. pmid:10811631
Kanzawa M et al. Involvement of osteoprotegerin/osteoclastogenesis inhibitory factor in the stimulation of osteoclast formation by parathyroid hormone in mouse bone cells. 2000 Eur. J. Endocrinol. pmid:10822231
Thirunavukkarasu K et al. The osteoblast-specific transcription factor Cbfa1 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function. 2000 J. Biol. Chem. pmid:10833509
Günther T and Schinke T Mouse genetics have uncovered new paradigms in bone biology. 2000 Trends Endocrinol. Metab. pmid:10856921
Rani CS and MacDougall M Dental cells express factors that regulate bone resorption. 2000 Mol. Cell Biol. Res. Commun. pmid:10860862
Tsurukai T et al. Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis. 2000 J. Bone Miner. Metab. pmid:10874596
Hofbauer LC and Heufelder AE Clinical review 114: hot topic. The role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases. 2000 J. Clin. Endocrinol. Metab. pmid:10902778
Lacey DL et al. Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo. 2000 Am. J. Pathol. pmid:10934148
Quinn JM et al. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. 2000 J. Bone Miner. Res. pmid:10934644
Min H et al. Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis. 2000 J. Exp. Med. pmid:10952716
Shiba H et al. Effects of ageing on proliferative ability, and the expressions of secreted protein, acidic and rich in cysteine (SPARC) and osteoprotegerin (osteoclastogenesis inhibitory factor) in cultures of human periodontal ligament cells. 2000 Mech. Ageing Dev. pmid:10958924
López FJ New approaches to the treatment of osteoporosis. 2000 Curr Opin Chem Biol pmid:10959765
Udagawa N et al. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. 2000 Endocrinology pmid:10965921
Yasuda H [A new paradigm of osteoclast biology: discovery of OCIF and ODF]. 2000 Seikagaku pmid:10967683
Teitelbaum SL Bone resorption by osteoclasts. 2000 Science pmid:10968780
Nakashima T et al. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. 2000 Biochem. Biophys. Res. Commun. pmid:10973797
Itoh K et al. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors. 2000 J. Bone Miner. Res. pmid:10976996

Table of Content